Increased ischaemia modified albumin following coronary artery bypass grafting

Biomarkers

Volumn 14, Issue 1, 2009, Pages 38-42

  Sbarouni, Eftihia ^a   Georgiadou, Panagiota ^a   Panagiotakos, Demosthenes ^a   Alivizatos, Petros A ^a   Voudris, Vassilis ^a  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

Biomarkers; Cardiac surgery; Ischaemia; Ischaemia modified albumin

Indexed keywords

ALBUMIN; CREATINE KINASE; ISCHEMIA MODIFIED ALBUMIN; TROPONIN I; ALBUMINOID;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART MUSCLE NECROSIS; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; HEART MUSCLE ISCHEMIA; MIDDLE AGED;

AGED; ALBUMINS; CORONARY ARTERY BYPASS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA;

EID: 66149158551     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.1080/13547500902730706     Document Type: Article

References (37)

1. Abboud H, Labreuche J, Meseguer E, Lavallee PC, Simon O, Olivot JM, Mazighi M,Dehoux M, Benessiano J, Steg PG, Amarenco P. (2007). Ischemia modified albumin in acute stroke. Cerebrovasc Dis 23:216-220.
2. Apple FS, Quist HE, Otto AP, Mathews WE, Murakami MM. (2002). Release characteristics of cardiac biomarkers and ischemiamodified albumin as measured by the albumin cobalt-binding test after marathon race. Clin Chem 48:1097-1100.
3. Apple FS, Wu AHB, Mair J, Ravklide J, Panteghini M, Tate J, Pagani F, Christenson RH, Mockel M, Danne O, Jaffe AS. (2005). Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem 51:810-824.
4. Aslan D, Apple F. (2004). Ischemia modified albumin measured by the albumin cobalt binding test: a clinical and analytical review. Lab Medicine 1309:44-47.
5. Bar-Or D, Rael LT, Bar-Or R, Slone DS, Mains CW, Rao NKR, Curtis G. (2008). The cobalt-albumin binding assay: Insights into its mode of action. Clin Chim Acta 387:120-127.
6. Bar-Or D, Winkler JV, VanBenthysen K, Harris L, Lau E, Hetzel FW. (2001). Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I. Am Heart J141:985-991.
7. Bhagavan NV, Lai EM, Rios PA, Yang J, Ortega-Lopez AM, Shinoda H, Honda SA, Rios CN, Sugiyama CE, Ha CE. (2003). Evaluation of human albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin Chem 49:581-585.
8. Bhatt DL, Topol EJ. (2005). Does creatine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005 Circulation 112:906-923.
9. Brener SJ, Lytle BW, Schneider JP, Ellis SG, Topol EJ. (2002). Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality. J Am Coll Cardiol 40:1961-1967.
10. Christenson RH, Duh SH, Sanhai WR, Wu AH, Holtman V, Painter P, Branham E, Apple FS, Murakami M, Morris DL. (2001). Characteristics of an albumin binding test for assessment of acute coronary syndrome patients: a multicenter study. Clin Chem 47:464-470.
11. Consuerga-Sanchez L, Boulas-Mosquera A, Sinha MK, Collinson PO, Gaze DC, Kaski JC. (2008). Ischemia-modified albumin predicts short-term outcome and 1-year mortality in patients attending the emergency department for acute ischemic chest pain. Heart Vessels 23:174-180.
12. Costa MA, Carere RG, Lichtenstein SV, Foley DP, de Valk V, Lindenboom W, Roos PCH, van Geldrop TR, Macaya C, Castanon JL, Fernandez-Avilez F, Gonzales JH, Heyer G, Unger F, Serruys PW. (2001). Incidence, predictors, and significancebypass surgery in the arterial revascularization study (ARTS). Circulation 104:2689-2693.
13. Dusek J, St'ásek J, Tichy M, Bis J, Gregor J, Vojacek J, Mesin V, Polansky P, Brtko M, Cernohorsky D. (2006). Prognostic significance of ischemia modified albumin after percutaneous coronary intervention. Clin Chim Acta 367:77-80.
14. Falkensammer J, Stojakovic T, Huber K, Hammerer-Lercher A, Gruber I, Scharnagl H, Fraedrich G, Santner W, Schocke M, Greiner A. (2007). Serum levels of ischemia-modified albumin in healthy volunteers after exercise induced calf-muscle ischemia. Clin Chem Lab Med 45:535-540.
15. Garrido IP, Roy D, Calvino R, Vazquez-Rodriguez JM, Aldama G, Cosin-Sales J, Quiles J, Gaze DC, Kaski JC. (2004). Comparison of ischemia-modified albumin levels in patients undergoing percutaneous coronary intervention for unstable angina pectoris with versus without collaterals. Am J Cardiol 93:88-90.
16. Gidenne S, Ceppa F, Fontan E, Perrier F, Burnat P. (2004). Analytical performance of the albumin cobalt binding (ACB) test on the Cobas Mira Plus analyzer. Clin Chem Lab Med 42:455-461.
17. Groal BL, Hillis GS, Gibson PH, Fazal MT, El Shafei H, Gibson G, Jeffrey RR, Buchan KG, West D, Cuthbertson BH. (2006). Relationship between postoperative cardiac troponin I levels and outcome of cardiac surgery. Circulation 114:1468-1475.
18. Januzzi JL, Lewandrowski K, MacGillivray TE, Newell JB, Kathiresan S, Servoss SJ, Lee-Lewandrowski E. (2002). A comparison of cardiac troponin T and creatine kinase-MB for patient evaluation after cardiac surgery. J Am Coll Cardiol 39:1518-1523.
19. Klatte K, Chaitman BR, Theroux P, Gavard JA, Stocke K, Boyce S, Bartels C, Keller B, Jessel A. (2001). Increased mortality after coronary artery bypass graft surgery is associated with increased levels of postoperative creatine kinase-myocardial band release. J Am Coll Cardiol 38:1070-1077.
20. Kurz K, Voelker R, Zdunek D, Wergeland R, Hess G, Ivandic B, Katus H, Giannitsis E. (2007). Effect of stress-induced reversible ischemia on serum concentrations of ischemia-modified albumin, natriuretic peptides and placental growth factor. Clin Res Cardiol 96:152-157.
21. Luyten CR, Overveld FJ, De Backer LA, Sadowska AM, Rodrigus IE, De Hert SG, De Backer WA. (2005). Antioxidant defence during cardiopulmonary bypass surgery. Eur J Cardiothorac Surg 27:611-616.
22. Morrow DA, de Lemos JA, Sabatine MS, Antman EM. (2003). The search for a biomarker of cardiac ischemia. Clin Chem 49:537-539.
23. Peacock F, Morris LD, Anwaruddin S, Christenson RH, Collinson PO, Goodacre SW, Januzzi JL, Jesse RL, Kaski JC, Kontos MC, Lefevre G, Mutrie D, Sinha MK, Uettwiller-Geiger D, Pollack CV. (2006). Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department. Am Heart J 152:253-262.
24. Quiles J, Roy D, Gaze D, Garrido IP, Avanzas P, Sinha M, Kaski JC. (2003). Relation of ischemia-modified albumin (IMA) levels following elective angioplasty for stable angina pectoris to duration of balloon-induced myocardial ischemia. Am J Cardiol 92:322-324.
25. Roy D, Quiles J, Gaze DC, Collinson P, Kaski JC, Baxter GF. (2006). Role of reactive oxygen species on the formation of the novel diagnostic marker ischaemia modified albumin. Heart 92:113-114.
26. Roy D, Quiles J, Sinha M, Floros D, Gaze D, Collinson P, Baxter GF, Kaski JC. (2004). Effect of radiofrequency catheter ablation on the biochemical marker ischemia-modified albumin. Am J Cardiol 94:234-236.
27. Roy D, Quiles J, Sinha M, Idama G, Gaze D, Kaski JC. (2004). Effect of direct-current cardioversion on ischemia-modified albumin in patients with atrial fibrillation. Am J Cardiol 93:366-368.
28. Sbarouni E, Georgiadou P, Panagiotakos D, Kyrzopoulos S, Tsiapras D, Voudris V, Kremastionos D. (2008). Ischemia modified albumin in relation to pharmacologic stress testing in coronary artery disease. Clin Chim Acta 396:58-61.
29. Sbarouni E, Georgiadou P, Panagiotakos D, Livanis EG, Theodorakis GN, Kremastinos DTh. (2007). Ischaemia modified albumin in radiofrequency catheter ablation. Europace 9:127-129.
30. Sbarouni E, Georgiadou P, Panagiotakos D, Livanis EG, Theodorakis GN, Kremastinos DT. (2008). The ischemia modified albumin in relation to pacemaker and defibrillator implantation. PACE 31:83-87.
31. Sbarouni E, Georgiadou P, Theodorakis GN, Kremastinos DT. (2006). Ischemia-modified albumin in relation to exercise stress testing. J Am Coll Cardiol 48:2482-2484.
32. Sinha M, Roy D, Gaze D, Collinson P, Kaski JC. (2004). Role of 'ischemia modified albumin', a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 21:29-34.
33. Sinha MK, Gaze DC, Tippins JR, Collinson PO, Kaski JC. (2003). Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation107:2403-2405.
34. Tassani P, Schad H, Winkler C, Bernhard A, Ettner U, Braun SL, Eising GP, Kochs E, Lange R, Richter JA. (2002). Capillary leak syndrome after cardiopulmonary bypass in elective, uncomplicated coronary artery bypass grafting operations: does it exist? J Thorac Cardiovasc Surg 123:735-741
35. Thygesen K, Alpert JS, White HD on behalf of the Joint ESC/ACCF/ AHA/WHF Task Force for the Redefinition of Myocardial Infarction. (2007). Eur Heart J 28:2525-2538.
36. Turedi S, Gunduz A, Mentese A, Karahan SC, Yilmaz SE, Eroglu O, Nuhoglu I, Turan I, Topbas M. (2007). Value of ischemia-modified albumin in the diagnosis of pulmonary embolism. Am J Emerg Med 25:770-773.
37. Van der Zee PM, Verberne HJ, Straalen JP, Sanders GT, Van Eck- Smit BL, de Winter RJ, Fischer JC. (2005). Ischemia-modified albumin measurements in symptom-limited exercise myocardial perfusion scintigraphy reflect serum albumin concentrations but not myocardial ischemia. Clin Chem 51:1744-1746.